Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 397 for “"lead compound"”.
-
Lead compound discovery for myotonic dystrophy
… treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing …
-
The Kinetics of Volatile Lead Compound Formation During Simulated Hazardous Waste Incineration
… produced anomalous results for air emissions of lead and other metals.</p> <p>To gain a better fundamental understanding of the generation of metal emissions, the kinetics of the formation of volatile pollutants in simulated incinerator kilns were experimentally examined as a function of …
-
PARAMETERIZATION OF AN ENERGY MODEL FOR SCORING OF ANTI-HIV DRUGS AND A COMPUTATIONAL METHOD OF LEAD COMPOUND OPTIMIZATION FOR DRUG DISCOVERY
… This method will be used for in silico compound screening to discover new potential anti-HIV drug candidates. The project also aims to develope a method of optimizing the charges of local parts of a ligand while keeping the rest of the charges roughly constant, rather than attempting to …
-
Synthesis and Anticancer Evaluation of Novel Pyrazolo[1,5-a]pyrimidines: Discovery of a Novel Lead Compound with Selective Activities Against VPS34 and JAK1-JH2 Pseudokinase
… funnel or purified via flash chromatography. The compounds were screened for anti-cancer activity against the A2780 Ovarian cancer cell line in vitro at 10 µM. The most active compound was the 2-(pyrazolo[1,5-a]pyrimidin-3-yl)benzothiazole, herein referred to as RD-I-53, which had an EC50 value of …
-
The Synthesis and Biological Evaluation of Anti-Adhesion Glycoconjugates Against Opportunistic Pathogenic Candida albicans
… formsof treatment.In this thesis, anti-adhesion compounds of Candida albicansto buccal epithelial cells (BEC) are considered. It was found that glycomimetics built around aromatic scaffolds could be potential anti-adhesion ligands. Using synthetic carbohydrate chemistry and Copper-Catalyzed …
-
Pharmacological Characterization of an Optimized Sigma Receptor Ligand
… of neurological complications some of which lead to neurodegenerative changes in the brain and hyperthermia. Currently, there are no FDA approved pharmacologic agents to treat the effects of methamphetamine. Recent evidence has suggested methamphetamine may, in part, produce some of its …
-
Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents
… Anibamine was used as a new anti-prostate cancer lead compound. To discover the pharmacophore, analogs of anibamine were designed using the “deconstruction-reconstruction-elaboration” approach and synthesized. The establishment of a stereoselective route to only one isomer was explored, to …
-
CLINICAL TRANSLATION OF A NOVEL FAPI DIMER [68Ga]Ga-LNC1013
… and clinical study were conducted to screen the lead compound with the potential for radionuclide therapy. Three new FAPI dimers were synthesized by linking two quinoline-based FAPIs with different spacers. The lead compound, [68Ga]Ga -LNC1013, was then evaluated in a pilot clinical PET imaging …
-
SYNTHESIS AND BIOLOGICAL EVALUATION OF CCR5 ANTAGONISTS AS NOVEL ANTI-PROSTATE CANCER AGENTS
… of PCa cell lines proliferation was explored. A lead compound has been identified which induced 100% inhibition of PCa cell proliferation at micromolar concentrations. Anibamine, the only natural product CCR5 antagonist, was also examined for its anti-proliferative activity and was found to …
-
Synthesis and Biological Evaluation of Various Derivatives of a Broad-Spectrum Anticancer Nucleoside
… moyl)amino]-N6-(N-phenylcarbamoyl)adenosine. This compound showed selective toxicity against human colon cancer cells in vitro with LC50's = 6--10 µM. It was hypothesized that the lead compound exerted its cytotoxic effects by interacting with a protein kinase. A systematic Structure Activity …
-
Targeting Bacterial and Fungal Pathogens through Novel Glycoconjugate-based Anti-Virulence Strategies
… presents the synthesis of novel derivatives of lead compounds developed through a combination of synthetic carbohydrate chemistry and Copper-catalysed Azide-Alkyne Cycloaddition (CuAAC). Chapter 2 describes the study of the structural requirements for an interesting intramolecular cyclisation …
-
Studies Towards the Development of a Novel Anti-Cancer Agent
… viride were developed and initially provided a lead compound for testing. Data relating to the anti-inflammatory activity of wortmannin analogues was available in the literature and was used in a computer modelling program SYBYL to build a structure activity relationship from which activity of …
-
Pharmacological Stimulation Of The Human Hsp70 Protein Disaggregase System
… against aggregated luciferase. We show that the lead compound can also stimulate the disaggregase activity of the Hsp70 system against αSyn amyloid fibrils. We found that certain members of the Hsp70 and Hsp40 chaperone families were unable to promote disaggregation and reactivation of soluble …
-
Design, synthesis and biological evaluation of cognitive enhancers acting through the potentiation of the AMPA receptors
… approach includes three major classes of compounds amongst which appear the benzothiadiazine 1,1-dioxides. The present thesis is a pursuit of the preliminary efforts that were published in 1998 and 2001 by our team. Based on promising in vitro results obtained with the lead compound 59, …
-
I) SYNTHESIS OF PLASMINOGEN ACTIVATOR (Pla) INHIBITORS IN YERSINIA PESTIS II) DEVELOPMENT OF SMALL MOLECULE INHIBITORS TO RESTORE NUCLEAR p27 AS A THERAPEUTIC METHOD FOR ENDOMETRIAL CANCER
… and inhibitory assay. Identification of a lead compound was conducted at Harvard Medical School. Derivatization of the lead gave analogs which will be tested for Pla inhibition to obtain IC50. Structure-activity relationship (SAR) study of the lead analogs can provide useful information to …
-
Design and synthesis of potential antimicrobial agents
… a database of commercially available drug-like compounds. From these results new potential ligands were designed that fitted appropriately into the active site and matched the functional groups and binding motifs founds therein. Some of these compounds and close analogues were then synthesized …
-
Design and Synthesis of 8-Trifluoromethyl-Substituted Heterocyclic Small Molecule Mitochondrial Uncouplers for the Treatment of Metabolic Diseases
… 8-trifluoromethyl-9H-purin-6- amines where lead compound SHK1112218 was identified as a highly potent mitochondrial uncoupler. Additionally, in an obesity reversal study in mice, treatment with lead compound SHK589 was observed to decrease body fat and maintain muscle mass. Together, these …
-
Developments in Thieno[3,2-c]isoquinoline Analogues as Potential Anti-Cancer Agents
Chemotherapies are the leading treatment for late-stage cancers. Despite their efficacy, these treatments are known to have harsh side effects caused by poor selectivity for cancerous cells over healthy cells. For this reason, the exploration of molecular targets specific to cancer cells is crucial …
-
The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter
… to develop MDR. There are multiple factors that lead to MDR but the factor that we will be exploring in this dissertation is the expression of multiple drug resistance gene 1 and the over expression of multi drug resistance protein 1(MDR1, also known as P-glycoprotein or P-gp). MDR1 has also been …
-
The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter
… to develop MDR. There are multiple factors that lead to MDR but the factor that we will be exploring in this dissertation is the expression of multiple drug resistance gene 1 and the over expression of multi drug resistance protein 1(MDR1, also known as P-glycoprotein or P-gp). MDR1 has also been …
Page 1 of 20